-transparent.png){kind=logo}
Grb2/Ash is composed of one SH2 and two SH3 domains and functions as an adapter linking tyrosine kinase receptors and Ras in fibroblasts. We have investigated the nature of proteins interacting with Grb2/Ash in hematopoietic cells. The product of the vav proto-oncogene (Vav) is expressed exclusively in hematopoietic cells and has guanine nucleotide exchange activity. Here we report that granulocyte/macrophage-colony- stimulating factor (GM-CSF), interleukin-3, and erythropoietin (Epo) induce rapid and transient tyrosine phosphorylation of Vav and that Vav is constitutively associated with the SH3 domain of Grb2/Ash in a human leukemia cell line UT-7. These data implicate Vav in a signaling pathway leading to activation of Ras or Ras-related proteins in hematopoietic cells. Furthermore, we have shown that the proto-oncogene c-cbl product (c-Cbl) is also tyrosine-phosphorylated by stimulation with GM-CSF or Epo and is constitutively associated with the SH3 domain of Grb2/Ash in UT-7. However, we could not find the homologous regions with guanine nucleotide exchange factors or GTPase-activating proteins in the c-cbl gene. Therefore, Grb2/Ash might also transduce a signal that is different from the signal leading to the small-G protein regulation.
Y Hanazono, and
H Odai, and
K Sasaki, and
A Iwamatsu, and
Y Yazaki, and
H Hirai
June 2007,
Annals of the New York Academy of Sciences,
Y Hanazono, and
H Odai, and
K Sasaki, and
A Iwamatsu, and
Y Yazaki, and
H Hirai
July 1997,
Journal of immunology (Baltimore, Md. : 1950),
Y Hanazono, and
H Odai, and
K Sasaki, and
A Iwamatsu, and
Y Yazaki, and
H Hirai
February 1994,
The Journal of biological chemistry,
Y Hanazono, and
H Odai, and
K Sasaki, and
A Iwamatsu, and
Y Yazaki, and
H Hirai
March 1994,
Cancer metastasis reviews,
Y Hanazono, and
H Odai, and
K Sasaki, and
A Iwamatsu, and
Y Yazaki, and
H Hirai
January 1988,
Medicina (Florence, Italy),
Y Hanazono, and
H Odai, and
K Sasaki, and
A Iwamatsu, and
Y Yazaki, and
H Hirai
January 1994,
Advances in experimental medicine and biology,
Y Hanazono, and
H Odai, and
K Sasaki, and
A Iwamatsu, and
Y Yazaki, and
H Hirai
December 2001,
Gene,
Y Hanazono, and
H Odai, and
K Sasaki, and
A Iwamatsu, and
Y Yazaki, and
H Hirai
May 1992,
Science (New York, N.Y.),
Y Hanazono, and
H Odai, and
K Sasaki, and
A Iwamatsu, and
Y Yazaki, and
H Hirai
April 2000,
Biochimica et biophysica acta,
Y Hanazono, and
H Odai, and
K Sasaki, and
A Iwamatsu, and
Y Yazaki, and
H Hirai
February 1996,
The Journal of biological chemistry,
